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Abstract—Development of CAD systems for detection of 
prostate cancer has been a recent topic of research and 
remains a challenging task. In this paper, we propose a 
novel method of prostate cancer detection within the 
peripheral zone. The key idea is to assume that every grey 
level could be associated with malignant or normal tissues 
by using a weighted probability. Based on the weighting, we 
use specific metrics to determine abnormality. We show 
experimental results to illustrate the performance of this 
method in comparison to some previous studies. Initial 
results show that our method achieved 81% correct 
classification result and 9% and 10% false positive and false 
negative results, respectively (sensitivity/specificity: 
0.85/0.72).  
 
Index Terms—Prostate Cancer Detection, Computer Aided 
Detection, Histogram Analysis, Grey Level Distribution, 
Prostate Abnormality 
 
I. INTRODUCTION 
With an estimate of 1.7 million cases globally by 2030 
[1], prostate cancer is one of the most common cancers 
affecting men, and is a leading cause of mortality in 
males [2]. In 2013, there were approximately 280,000 and 
40,000 cases in the United State and United Kingdom, 
respectively [1]. Clinical diagnostic tools such as 
prostate-specific antigen (PSA) level, digital rectal 
examination (DRE), transrectual ultrasound (TRUS) and 
biopsy tests are used globally despite their inconsistent 
results (0.51-0.89 and 0.67-0.87 sensitivity and 
specificity, respectively) [3]. Some of these methods are 
invasive and patients can suffer stress from false-positive 
test results, subsequent evaluation, therapy, and "over-
treatment" [2]. 
Prostate magnetic resonance imaging (MRI) has the 
potential to improve the accuracy of clinical diagnostic 
tests [4]. Therefore the main goal of our research is to 
develop computer aided diagnosis (CAD) tools towards 
the detection of prostate abnormalities. Since 80-85% of 
the cancers arise within the peripheral zone [5], the 
proposed method only considered abnormalities that 
occur within this region. There have been several studies 
which used only the peripheral zone of the prostate [6-8] 
and allows us to compare our quantitative results to these 
previous studies. Fig. 1 shows an example of prostate 
                                                          
 
MRI image with its ground truth delineated by an expert 
radiologist and Fig. 2 shows a schematic overview of a 
prostate containing a tumor. 
 
  
 
Figure 1.The ground truth of prostate gland, central zone and tumor and 
represented in red, yellow and green, respectively. 
 
 
 
Figure 2. CZ = central zone, PZ = peripheral zone, TZ=transitional zone 
T = tumor. 
 
The proposed method compares grey level histograms 
from each slice with models (e.g. normal and malignant 
histograms models) which were constructed based on 
training data the distribution of grey level. Subsequently, 
we use specific metrics to determine abnormality. There 
are several methods in the literature which have used 
histogram analysis techniques [9-12]. A method proposed 
in [9] characterised each suspicious region of interest by 
performing histogram analysis on multiparametric MR 
images. On the other hand, [10] used colour channel 
histograms to capture the pattern of malignancy tissues in 
Gleason graded images. Moreover, [11] reports that 
features based histograms can achieve high sensitivity 
and specificity which is similar to some other features 
such as Gray Level Co-occurrence matrix (GLCM) and 
Grey Level Run-Length matrix (GLRLM). Finally, [12] 
used T2-weighted signal intensity histogram skewness as 
one of their features in differentiating between malignant 
and normal tissues. In terms of using grey level properties 
in detecting abnormalities, several studies have been done 
in medical image analysis application. The authors in [13] 
proposed a method for recognition of lung abnormalities 
based on four different templates describing typical 
geometry and grey level distribution of lung modules 
[13]. On the other hand, Yu [14] proposed a method 
which is relying on spatial grey level dependence for 
detecting and locating brain abnormality. Finally, the 
authors in [15] proposed a method using the distribution 
of grey level variations for abnormality detection in 
mammography.  
In this paper we propose a new method for detecting 
prostate cancer within the peripheral zone using the 
distribution of grey levels. In comparison to the existing 
methods (detecting prostate cancer in medical images) in 
the literature, our method is different in the sense that we 
do not rely on texture features such as blobs and 
statistical features. The methods in [16], [17] and [18] 
used texture features to classify malignant and normal 
tissue. Secondly, our method uses a single modality (T2-
Weighted MRI) unlike the method in [19], which used 
multimodality, i.e. diffusion MRI and MR Spectroscopy. 
Similarly, the method proposed in [9] used 
multiparametric MR, i.e. T1- and T2-weighted imaging. 
Finally, the proposed method is purely based on the grey 
levels information whereas the method in [9] used 
additional clinical diagnostic information such as biopsy 
tests in deciding whether cancer is truly present or not.  
II. MODELLING THE PERIPHERAL ZONE 
Since the proposed method only considers malignant 
tissues/regions within the PZ, it is important to define the 
PZ region. We use a simple method proposed in [20, 21] 
which uses a quadratic equation             to 
define the boundary of PZ based on three vertex 
coordinates    ,    and    (which can be found based on 
the prostate’s boundary). Fig. 3 shows an example how 
the PZ region is defined. The coordinates of   ,    and    
can be determined based on the Cp (central coordinate), 
minimum and maximum x and y coordinates (xmin, ymin, 
xmax and ymax) . A detailed description of the method can 
be found in [20, 21]. 
 
 
 
Figure 3: Prostate gland (red) and the defined PZ (indigo region) and its 
boundary (green) which goes through   ,    and   . 
III. METHODOLOGY 
Fig. 4 shows the overview of the proposed algorithm. 
In summary, the methodology relies on the distribution of 
grey level within the histograms which were constructed 
based on the grey level occurrence within 44 malignant 
and normal regions. The histogram models represent the 
weighting values for every grey level. Based on the 
constructed histograms (88 slices) for each new slice, the 
histogram will be compared with the histogram models 
constructed in the early phase (yellow region in Fig. 4).  
 
 
 
 
 
 
 
 
 
 
Figure 4: The overview of the proposed methodology 
 
A. Construction of Histograms 
For every slice, the proposed method constructs the 
first histogram (   ) by taking every pixel intensity 
within the malignant region (note that all malignant 
regions were delineated by an expert radiologist) and 
each pixel is classified according to its intensity into an 
appropriate grey level. The second histogram (  ) is 
constructed using the same process with     but taking 
normal regions instead. Normal regions are taken from 
the whole PZ region (with condition there is no tumors 
found within the PZ) as shown in Fig. 3 indigo region. 
This means    and    contain the distribution of 
malignant and normal grey level, respectively. Since 
every image size is 16 bits, there is a total of 65, 536 
grey.  There were 44 malignant and normal regions (in 
total 88 regions) taken from 44 slices (in total 88 slices all 
from 20 patients) to construct    and   . 
Mathematically, this process can be presented in (1), (2), 
(3) and (4).  
 
   {              }   (1) 
   {              }   (2) 
   {           }  (3) 
   {               }  (4) 
 
where ,  ,   and     represent the     region (or grey 
level), every grey level, malignant and normal region, 
respectively. This means, there are 44 histograms in total 
from 44 malignant slices (another 44 histograms from 
normal slices). Finally, we combine all histograms using 
(3) and (4) to produce the resulting models. Fig. 5 
illustrates an example of this process.  
 
 
 
Figure 5: An example of histogram result (  ). The x and y axis 
represent the grey level location and the frequency of occurrence for 
every grey level. 
   
Fig. 5 shows an example of the construction of    
based the n slices (in our case 44 slices). Note that the 
pixel intensities are only taken within the malignant 
region which is within the red boundary in Fig. 5. The 
process is similar when constructing    but taking the PZ 
region as defined in Fig. 3. To this point we have 
constructed two histogram models which are    and    
where both histograms store the frequency of grey level 
occurrence from malignant and normal regions, 
respectively. However, since many grey levels occur in 
both regions, we need to identify the distinctive grey 
levels which occur only in malignant or normal regions, 
and grey levels that occur both in malignant and normal 
regions. These allow us to differentiate malignant and 
normal grey tissues. These can be found by finding the 
intersection of     and    as shown in (5). In our case, 
intersection means a particular grey level can be found in 
both malignant and normal regions (i.e. grey level at the 
position 3990
th
 occurs in    and   , see Fig. 9) . 
 
                             (5) 
 
where    is the histogram contains all the grey levels 
occur both in malignant and normal regions. Each grey 
level’s frequency in    is the mean of corresponding 
frequencies in    and    (e.g.              
        ) with condition that the element     is in    
and   . Fig. 6 shows an illustration of this process in a 
Van diagram. From the van diagram, we can see that    
and   , have their unique grey levels. The values in    
represents grey levels 3, 50, 234 and 941 occur in both 
   and   . This means, prostate tissues which are fall in 
these grey level values are classified as malignant or 
normal. 
 
 
 
Figure 6:    contains all the overlap grey levels from    and  . Each 
element in the Van diagram represents the grey level. 
  
By the end of this phase, we have three histogram 
models which present the only malignant (  ), only 
normal (  ) and malignant and normal (  ) grey levels. 
Fig. 7 and 8 show examples of malignant and normal 
grey level distributions from grey level 38,000 to 39,000, 
respectively. We chose only 1000 grey levels in the 
following examples so the differences are visible.  
 
 
 
Figure 7: Malignant grey level distribution for 1000 grey levels. 
 
 
 
Figure 8: Normal grey level distribution for 1000 grey levels 
 
On the other hand, Fig. 9 shows an example of grey level 
distribution of    for the same 1000 grey levels.  
 
 
 
Figure 9: Grey level distribution for   . 
 
Based on the examples in Fig. 7- 9 we can clearly see that 
normal regions have higher occurrence within this range 
and very small occurrence for malignant grey levels 
within this range. However, it is possible that all grey 
levels in malignant regions only occur in    (e.g. if all 
grey levels occur in     we need further steps to 
determine abnormality). To reduce this problem we need 
to extract two more histograms from    . Both 
histograms (    and   ) represents the distribution of 
overlapping malignant and benign grey levels, 
respectively. In contrast to   ,    and    were 
constructed based on the exact number of occurrence of 
grey levels whereas    is based on the average 
occurrence number of grey levels of     and    . 
Therefore, every grey level now has a weighted value and 
using these histogram models (   ,   ,   ,    and   ) 
we could estimate the probability of abnormality using 
specific metrics.     
B. Histogram Normalisation 
Since the sum of    outweighs considerably high the 
sum of    and     (caused false negative results), all 
models need to be normalised to ensure the weighting 
values for all grey levels are distributed evenly (used for 
the first metric only). By normalising all histogram 
models the sum for every histogram is equal to 1. The 
normalisation can be done using the following equation 
 
       
     
∑     
   (6) 
 
where    {         } and  (small  ) indicates a 
normalised histogram. Therefore we get an equal 
summation of histogram but still different distributions 
and weighting value for every grey level’s location. 
 
 
 
 
 
 
C. Abnormality Detection 
In the proposed method, abnormality detection is 
performed by calculating specific information from every 
histogram which is extracted from PZ. We use the 
following metrics to measure abnormality. 
 
1) The sum of histogram multiplication (    ) for 
each   with each of     (e.g.     and     ). This 
can be calculated using the following equation  
 
     ∑                  (7) 
 
This metric indicates the product of probability 
when every element in    is multiplied with every 
element (frequency) in   . This means, the higher 
the value of      the more chance the slice has a 
tumor. For instance,            means the 
malignant product of probability is higher when 
multiplied with    compared to   . A large 
number of      indicates there are many grey 
levels in    have the same grey level in    
(similar case in      and     ).  
2) The histogram intersection (     ) [22] between 
    and    which can be calculated using the 
following  
 
     ∑     {              }  (8) 
 
Based on (8), we do not use the normalised 
histograms (   ) but    (denormalised histogram) 
instead, because normalised histograms could 
affect the value of histogram intersection due to 
the small values in     which lead to incorrect 
results. We used this metrics as it has been 
successfully used for similarity measure in many 
different applications including medical image 
analysis. This metric measures the closeness of 
match between two histograms (in our case    
and   ) . Higher value of      indicates higher 
probability of the histograms is similar. In the 
proposed method, this matric is used to measure 
the closeness of a match between every   with 
the histogram models. The closer the match with 
model the higher the value of     . Finally, 
higher value means most gray levels in both 
histograms are distributed equally. 
 
 
 
Figure 10: Flow chart decision rules. 
 
Finally, now we have seven variables (     ,    , 
     ,     ,      ,     and     ) which will be used 
to determine as whether abnormality is present or not 
based on the decision rules in Fig. 10. It should be noted 
that there are other metrics in the literature [23] available 
but these will be investigated in the future. Based on Fig. 
10, it is clearly shows that if     ,      or     value is 
higher than      ,     or     indicates higher 
probability of the prostate being abnormal. Similarly 
when the prostate’s slice is more likely to be benign, the 
values of      ,     or     are greater than       , 
    or     . In the next section we will present our 
experimental results. 
IV. EXPERIMENTAL DATA 
In this study, we used 243 slices of T2-Weighted MRI 
images taken 35 different patients aged 47 to 79. The data 
contains 88 slices of training data from 20 patients and 
50% of the training data are malignant and the other half 
is normal. For evaluation purpose we used 155 slices of 
MRI images from 35 patients and 105 slices of them are 
malignant and 50 slices are normal. Our data were 
collected from Norfolk and Norwich Hospital University 
and for every slice all ground truths (prostate gland, 
central zone and tumor) were delineated by an expert 
radiologist. 
 
 
 
V. EXPERIMENTAL RESULTS 
This section presents the experimental results based on 
155 slices T2-Weighted MRI images with 105 slices are 
malignant and 50 slices are normal from 35 different 
patients aged 49 to 74. The prostate, cancer and central 
zones were delineated by an expert radiologist on each of 
the images. Each slice was analysed and classified as to 
whether the prostate contains abnormality based on the 
methodology described in section three. Next, we 
compared the result with the ground truth as to whether 
the prostate contains cancer regions or not. An 
abnormality is considered to have been detected if the 
classification result is correct in comparison with the 
ground truth. We use several quantitative measures to 
evaluate the results such as sensitivity (   ), specificity 
(   ) and Accuracy   (   ). Each of these metrics can be 
calculated using the following equations 
 
    
  
     
   (9) 
 
    
  
     
   (10) 
 
    
     
           
  (11) 
 
where TP and FP denote the numbers of true positive and 
false positive, respectively. Similarly, TN and FN show 
the numbers of true negatives and false negatives. 
Accuracy means the number of correct classified slices 
out of the total number of slices. Sensitivity measures the 
proportion of actual positives which are correctly 
identified (in this case the percentage of malignant slice 
which are correctly identified) whereas specificity 
measures the proportion of actual negatives which are 
correctly identified (in this study the percentage of 
normal slice which are correctly identified). 
The proposed method achieved 81% correct accuracy, 
which means 126 slices were classified correctly with 
0.85 and 0.72 sensitivity and specificity, respectively. On 
the other hand, the proposed method produced 9% and 
10% false positive and false negative results, 
respectively. In comparison with existing methods in the 
literature the proposed method achieved similar results. 
Nevertheless, it is extremely difficult to make a 
qualitative comparison due to the differences in datasets 
(different modalities such as T2-weighted (T2-W) MRI, 
diffusion-weighted (DWI) MRI, dynamic contrast 
enhanced (DCE) MRI, Magnetic resonance spectroscopy 
(MRS), etc.) and frameworks used by the other methods. 
However, to compare the proposed method, we cite 
several methods which have similar goals (detecting 
prostate cancer). There are many other methods in the 
literature but it is difficult to gather all of those methods 
(also space limitation) and we selected these methods 
(see Table 1) because they have at least one of the 
qualitative results (e.g. sensitivity) and it is clearly stated 
the number of cases used in the evaluation. 
TABLE I.  FROM THE LEFT COLUMN REPRESENTS THE AUTHORS, 
NUMBER OF PROSTATES/PATIENTS, ACCURACY RATE, SENSITIVITY, 
SPECIFICITY AND MODALITIES, RESPECTIVELY 
Authors # Acc Sen Spe Mod 
Sung et al.[24] 42 89 89 89 DCE 
Vos et al.[9] 29 89 - - T2-
W+DCE 
Ampeliotis at 
al.[3] 
10 87 - - T2-
W+DCE 
Rampun et 
al.[21] 
19 85 82 87 T2-W 
Tiwari et 
al.[25] 
19 84 - - T2-
W+MRS 
Artan and 
Yetik.[8] 
15 82 76 86 DCE 
Our method 35 81 85 72 T2-W 
Castaneda et 
al.[26] 
15 80 67 86 CrW 
Reinsberg et 
al.[27] 
42 - 81-93 64-73 DWI+MRS 
Litjens et 
al.[28] 
188 - 84 - DWI+DCE 
Futterer et 
al.[29] 
6 - 83 83 T2-W 
Girouin et 
al.[30] 
46 - 78-81 32-56 T2-W 
Llobet et 
al.[18] 
303 - 57 61 Ultrasound 
 
Table 1 presents the experimental results of thirteen 
different methods including the proposed method and 
their accuracy, sensitivity, specificity and modalities. All 
methods were ordered based on accuracy, sensitivity and 
specificity accordingly. Note that some of the authors did 
not include one/two of these qualitative results (indicated 
as ‘-’). The method proposed in [9] and [24] achieved the 
highest correct classification rate (89%) followed by the 
method in [3] with 87% accuracy. Our method has 
similar accuracy result with the method in [26] with just 
1% higher. In addition, the proposed method reported 
similar sensitivity with the methods proposed in [21], 
[28] and [29] and the method of [24] reminds 89%. 
Although the method proposed in [27] achieved the 
highest sensitivity but the authors reported inconsistency 
of 81%-93%. The method in [18] achieved the lowest 
accuracy which is 57% whereas the method in [8] and 
[26] produced 76% and 67% sensitivity, respectively. On 
the other hand, the methods in [21], [26], [8] and [29] 
achieved high specificity 87%, 86%, 86% and 83%, 
respectively. The proposed method achieved only 72% 
but it is still higher than the methods proposed in [18] and 
[30].  
These comparisons are subjective because accuracy, 
sensitivity and specificity are highly influenced by the 
number of datasets, different modalities and methods’ 
framework. For instance, although the method proposed 
in [26] and [29] achieved 86% and 83% specificity, 
respectively; the evaluation is based on smaller numbers 
of dataset (6 and 15 patients, respectively). On another 
study [31] shows higher sensitivity and specificity of 
93% and 96%, respectively but based on 46 ultrasound 
images. Similarly, the method proposed in [24] and [9] 
achieved the highest accuracy but based on DCE and T2-
W+DCE modalities, respectively. Therefore it is 
extremely difficult to make a direct comparison either 
quantitatively or qualitatively. However, for indirect 
comparison purpose our method achieved comparable 
results with the state of art. One obvious drawback of this 
method is since it entirely relying on the grey level 
distribution, the metrics could give inaccurate results if 
the data is heavily affected by noise (due to change of 
pixel intensity affected by noise).  
VI. CONCLUSIONS 
 We have introduced a novel method for automated 
prostate cancer detection using grey level distribution. 
The proposed method achieved similar results to some of 
the methods in the literature. The proposed method shows 
that prostate abnormalities could be detected using grey 
level distribution by giving a weighted value (by 
normalising the histogram models) for each of the grey 
levels. Moreover, in this paper we have shown the 
importance of grey-level values in detecting prostate 
abnormality by assigning every grey level into different 
classes (e.g. malignant or benign) and assigning a 
weighting value for every single grey level’s location. In 
short, with 9% and 10% false positive and false negative 
results, respectively we have achieved comparable results 
(81% accuracy out of 35 patients). Although it is difficult 
to make a quantitative comparison with the methods in 
Table 1 due the differences in datasets and frameworks, 
the main objective to show the potential of grey level 
distribution in detecting prostate cancer because it has 
been showed its potential in different human’s body such 
as breast [15], lung[13] and brain[14]. Finally, the next 
stage of this research is to test it on a larger dataset with 
several combination methods [20, 21] and applying a 
robust noise reduction method to improve its sensitivity 
and specificity. 
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